These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
179 related items for PubMed ID: 38753154
1. SPG21, a potential oncogene targeted by miR-128-3p, amplifies HBx-induced carcinogenesis and chemoresistance via activation of TRPM7-mediated JNK pathway in hepatocellular carcinoma. Zhou P, Yao W, Liu L, Yan Q, Chen X, Wei X, Ding S, Lv Z, Zhu F. Cell Oncol (Dordr); 2024 Oct; 47(5):1757-1778. PubMed ID: 38753154 [Abstract] [Full Text] [Related]
2. Hepatitis B virus X protein inhibits tumor suppressor miR-205 through inducing hypermethylation of miR-205 promoter to enhance carcinogenesis. Zhang T, Zhang J, Cui M, Liu F, You X, Du Y, Gao Y, Zhang S, Lu Z, Ye L, Zhang X. Neoplasia; 2013 Nov; 15(11):1282-91. PubMed ID: 24339740 [Abstract] [Full Text] [Related]
3. TRERNA1 upregulation mediated by HBx promotes sorafenib resistance and cell proliferation in HCC via targeting NRAS by sponging miR-22-3p. Song W, Zheng C, Liu M, Xu Y, Qian Y, Zhang Z, Su H, Li X, Wu H, Gong P, Li Y, Fan H. Mol Ther; 2021 Aug 04; 29(8):2601-2616. PubMed ID: 33839325 [Abstract] [Full Text] [Related]
4. Upregulated in Hepatitis B virus-associated hepatocellular carcinoma cells, miR-331-3p promotes proliferation of hepatocellular carcinoma cells by targeting ING5. Cao Y, Chen J, Wang D, Peng H, Tan X, Xiong D, Huang A, Tang H. Oncotarget; 2015 Nov 10; 6(35):38093-106. PubMed ID: 26497554 [Abstract] [Full Text] [Related]
5. Hepatitis B virus X protein accelerates hepatocarcinogenesis with partner survivin through modulating miR-520b and HBXIP. Zhang W, Lu Z, Kong G, Gao Y, Wang T, Wang Q, Cai N, Wang H, Liu F, Ye L, Zhang X. Mol Cancer; 2014 May 28; 13():128. PubMed ID: 24886421 [Abstract] [Full Text] [Related]
6. MicroRNA-98-5p Inhibits Tumorigenesis of Hepatitis B Virus-Related Hepatocellular Carcinoma by Targeting NF-κB-Inducing Kinase. Fei X, Zhang P, Pan Y, Liu Y. Yonsei Med J; 2020 Jun 28; 61(6):460-470. PubMed ID: 32469170 [Abstract] [Full Text] [Related]
7. Hepatitis B virus X protein promotes proliferation of hepatocellular carcinoma cells by upregulating miR-181b by targeting ING5. Xie X, Xu X, Sun C, Yu Z. Biol Chem; 2018 May 24; 399(6):611-619. PubMed ID: 29604207 [Abstract] [Full Text] [Related]
8. A positive-feedback loop between HBx and ALKBH5 promotes hepatocellular carcinogenesis. Qu S, Jin L, Huang H, Lin J, Gao W, Zeng Z. BMC Cancer; 2021 Jun 10; 21(1):686. PubMed ID: 34112124 [Abstract] [Full Text] [Related]
9. Role of microRNA-210-3p in hepatitis B virus-related hepatocellular carcinoma. Morishita A, Fujita K, Iwama H, Chiyo T, Fujihara S, Oura K, Tadokoro T, Mimura S, Nomura T, Tani J, Yoneyama H, Kobayashi K, Kamada H, Guan Y, Nishiyama A, Okano K, Suzuki Y, Himoto T, Shimotohno K, Masaki T. Am J Physiol Gastrointest Liver Physiol; 2020 Mar 01; 318(3):G401-G409. PubMed ID: 31905024 [Abstract] [Full Text] [Related]
10. miR-3928v is induced by HBx via NF-κB/EGR1 and contributes to hepatocellular carcinoma malignancy by down-regulating VDAC3. Zhang Q, Song G, Yao L, Liu Y, Liu M, Li S, Tang H. J Exp Clin Cancer Res; 2018 Jan 29; 37(1):14. PubMed ID: 29378599 [Abstract] [Full Text] [Related]
11. miR-338-3p is down-regulated by hepatitis B virus X and inhibits cell proliferation by targeting the 3'-UTR region of CyclinD1. Fu X, Tan D, Hou Z, Hu Z, Liu G. Int J Mol Sci; 2012 Jan 29; 13(7):8514-8539. PubMed ID: 22942717 [Abstract] [Full Text] [Related]
12. MiR-19a, miR-122 and miR-223 are differentially regulated by hepatitis B virus X protein and involve in cell proliferation in hepatoma cells. Yu G, Chen X, Chen S, Ye W, Hou K, Liang M. J Transl Med; 2016 May 05; 14(1):122. PubMed ID: 27150195 [Abstract] [Full Text] [Related]
13. Hepatitis B virus X protein upregulates alpha-fetoprotein to promote hepatocellular carcinoma by targeting miR-1236 and miR-329. Zhang C, Liu P, Zhang C. J Cell Biochem; 2020 Mar 05; 121(3):2489-2499. PubMed ID: 31680299 [Abstract] [Full Text] [Related]
14. Dynamic expression of ZNF382 and its tumor-suppressor role in hepatitis B virus-related hepatocellular carcinogenesis. Dang S, Zhou J, Chen Y, Chen P, Ji M, Shi B, Yang Q, Hou P. Oncogene; 2019 Jun 05; 38(24):4804-4819. PubMed ID: 30804458 [Abstract] [Full Text] [Related]
15. Hepatitis B virus X protein boosts hepatocellular carcinoma progression by downregulating microRNA-137. Gao Y, Gu J, Wang Y, Fu D, Zhang W, Zheng G, Wang X. Pathol Res Pract; 2020 Jun 05; 216(6):152981. PubMed ID: 32527447 [Abstract] [Full Text] [Related]
16. Influence of miR-520e-mediated MAPK signalling pathway on HBV replication and regulation of hepatocellular carcinoma cells via targeting EphA2. Tian JH, Liu WD, Zhang ZY, Tang LH, Li D, Tian ZJ, Lin SW, Li YJ. J Viral Hepat; 2019 Apr 05; 26(4):496-505. PubMed ID: 30521133 [Abstract] [Full Text] [Related]
17. Hepatitis B virus X protein promotes hepatocellular carcinoma transformation through interleukin-6 activation of microRNA-21 expression. Li CH, Xu F, Chow S, Feng L, Yin D, Ng TB, Chen Y. Eur J Cancer; 2014 Oct 05; 50(15):2560-9. PubMed ID: 25087183 [Abstract] [Full Text] [Related]
18. Carboxyl-terminal truncated HBx contributes to invasion and metastasis via deregulating metastasis suppressors in hepatocellular carcinoma. Li W, Li M, Liao D, Lu X, Gu X, Zhang Q, Zhang Z, Li H. Oncotarget; 2016 Aug 23; 7(34):55110-55127. PubMed ID: 27391153 [Abstract] [Full Text] [Related]
19. TGF-β1 accelerates the hepatitis B virus X-induced malignant transformation of hepatic progenitor cells by upregulating miR-199a-3p. Dong KS, Chen Y, Yang G, Liao ZB, Zhang HW, Liang HF, Chen XP, Dong HH. Oncogene; 2020 Feb 23; 39(8):1807-1820. PubMed ID: 31740785 [Abstract] [Full Text] [Related]
20. Upregulated FoxM1 expression induced by hepatitis B virus X protein promotes tumor metastasis and indicates poor prognosis in hepatitis B virus-related hepatocellular carcinoma. Xia L, Huang W, Tian D, Zhu H, Zhang Y, Hu H, Fan D, Nie Y, Wu K. J Hepatol; 2012 Sep 23; 57(3):600-12. PubMed ID: 22613004 [Abstract] [Full Text] [Related] Page: [Next] [New Search]